Roger Ulrich, Ph.D.

Chief Development Officer

Roger Ulrich has been the Chief Development Officer at Calistoga Pharmaceuticals since co-founding the company in 2006. Dr. Ulrich has more than 24 years of drug discovery and development experience primarily in oncology, metabolic and infectious diseases. Prior to Calistoga, Dr, Ulrich was Senior Scientific Director with Merck Research Laboratories-Rosetta Inpharmatics where he led a team investigating molecular mechanisms and biomarkers for adverse drug reactions. Prior to Merck, Dr. Ulrich held various scientific and leadership positions including Director of Regulatory Toxicology and Safety Pharmacology with Abbott Laboratories, and as Senior Scientist with The Upjohn Company and Pharmacia & Upjohn Inc. Prior to that he worked at West Virginia and Michigan State Universities, and at Argonne National Laboratories. Dr. Ulrich has authored more than 115 publications and is an internationally recognized lecturer on toxicology, genomics and drug discovery. He continues to serve on various editorial boards, government and academic advisory boards and working committees.

Dr. Ulrich received his Bachelor of Arts degree in Biology/Chemistry and his Masters of Arts in Biomedical Sciences from Western Michigan University. He received his doctorate in Cellular and Molecular Biology from West Virginia University, and is a Fellow of the Academy of Toxicological Sciences.